ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,684 | +4.2% | 16,090 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $316,529 | +12.1% | 15,930 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $282,474 | -12.5% | 16,490 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $322,709 | +12.8% | 16,490 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $286,000 | +16.3% | 17,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -11.2% | 17,900 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $277,000 | -27.5% | 17,490 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $382,000 | -26.4% | 17,490 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $519,000 | -32.5% | 17,364 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $769,000 | +15.5% | 17,364 | +15.6% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | -19.6% | 15,016 | -0.6% | 0.00% | -50.0% |
| Q4 2020 | $828,000 | +137.2% | 15,106 | -1.0% | 0.00% | +100.0% |
| Q3 2020 | $349,000 | +14.1% | 15,266 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $306,000 | – | 14,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |